Free Trial

SI-BONE Q4 2023 Earnings Report

SI-BONE logo
$13.99 -0.04 (-0.29%)
As of 03/27/2025 04:00 PM Eastern

SI-BONE EPS Results

Actual EPS
-$0.27
Consensus EPS
-$0.29
Beat/Miss
Beat by +$0.02
One Year Ago EPS
N/A

SI-BONE Revenue Results

Actual Revenue
$38.86 million
Expected Revenue
$38.60 million
Beat/Miss
Beat by +$260.00 thousand
YoY Revenue Growth
N/A

SI-BONE Announcement Details

Quarter
Q4 2023
Time
N/A

Conference Call Resources

Conference Call Audio

Slide Deck

Remove Ads

SI-BONE Earnings Headlines

SI-BONE, Inc. (NASDAQ:SIBN) Short Interest Up 17.8% in February
A $6.9 Trillion Cash Tsunami Is Coming – Move Your Money NOW
Expert: "Prepare For the Mother of All Melt-Ups" In the wake of Wall Street volatility, stock-picking legend (with 255 winners to his name) has just predicted a dramatic - and completely unexpected - stock market rebound... as a $6.9 trillion cash tsunami floods back into stocks. He just shared the name of one stock which could potentially surge 300% or higher, free of charge.
Q4 2024 SI-BONE Inc Earnings Call
Bank of America Securities Reaffirms Their Buy Rating on SI-Bone (SIBN)
See More SI-BONE Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like SI-BONE? Sign up for Earnings360's daily newsletter to receive timely earnings updates on SI-BONE and other key companies, straight to your email.

About SI-BONE

SI-BONE (NASDAQ:SIBN), a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

View SI-BONE Profile

More Earnings Resources from MarketBeat